Table 1 Inclusion and exclusion criteria

1. Adults over 18 years old of both sexes

2. Clinical indication for PPV alone or associated with facoemulsification or scleral buckling

3. Under treatment with any of the following oral anticoagulants: acenocumarol, dabigatran, rivaroxaban, apixaban or edoxaban

4. Able to give informed consent for PPV and to participate in the trial

1. Patients unable to be operated under retrobulbar anaesthesia

2. Patients on antiplatelet therapy except if the antiaggregation is with acetylsalicylic acid

3. Patients who have recently started oral anticoagulation (less than 1 month before screening)

4. Any medical, psychological, psychiatric, geographic or social situation that could interfere with the participation of the patient in the trial or with the follow-up and adherence with the protocol and the evaluation of the results of the present trial